Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MUC1 - Poly-ICLC Vaccine in Advanced Colorectal Adenoma
NCT00773097Phase 2Completed
- Start
- Oct 2008
- Primary completion
- Oct 2011
- Modality
- Peptides, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of MUC1 peptide-poly-ICLC vaccine in Colorectal Adenoma (CRA), colorectal cancer (CRC). Started Oct 2008; status: completed.
02
Drugs
MUC1 peptide-poly-ICLC vaccine
03
Conditions
Colorectal Adenoma (CRA)colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00773097.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00773097.